Martin G. Friedman
Direttore/Membro del Consiglio presso JDS Therapeutics LLC
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michael S. Satow | M | - |
JDS Therapeutics LLC
 JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 13 anni |
| Pedro Gonzalez de Cosio | M | - |
Pharmakon Advisors LP
 Pharmakon Advisors LP Investment ManagersFinance Pharmakon Advisors LP (Pharmakon Advisors) is an independent private equity/venture capital firm founded in 2009, by Pablo Gerardo Legorreta and Pedro Gonzalez de Cosio. The firm is headquartered in New York, US. | 15 anni |
| Phillip M. Satow | M | 81 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 13 anni |
| James R. Komorowski | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Pablo Legorreta | M | 60 |
Pharmakon Advisors LP
Pharmakon Advisors LP Investment ManagersFinance Pharmakon Advisors LP (Pharmakon Advisors) is an independent private equity/venture capital firm founded in 2009, by Pablo Gerardo Legorreta and Pedro Gonzalez de Cosio. The firm is headquartered in New York, US. | 15 anni |
| Vasant Narasimhan | M | 48 | 19 anni | |
| Frederic Poses | M | 80 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Joseph R. Gregory | M | 70 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Bob Johnston | M | 87 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Michael Koby | M | 51 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Richard Scott Pechter | M | 78 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Michael V. Quinn | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 12 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Juan Andres | M | 59 | 12 anni | |
| Joachim P. H. Schupp | M | 71 | 19 anni | |
| Muriel Cottard | M | - | 14 anni | |
| Eric Floyd | M | 61 | - | |
| Gina Massa Mias | F | - | - | |
| Antony Mattessich | M | 57 | 2 anni | |
| Diane E. Sugrue | F | - | 9 anni | |
| Ginger Gregory | M | 56 | 7 anni | |
| Alessandro Riva | M | 63 | 11 anni | |
| Edward Vlacich | M | - | - | |
| Jonathan Peacock | M | 66 | 5 anni | |
| Ian Garland | M | 59 | - | |
| Jessica Mann | M | - | - | |
| Mason W. Freeman | M | 73 | 2 anni | |
| Peder Sven Walberg | M | 50 | 2 anni | |
| Peter Nicklin | M | 61 | 2 anni | |
| François Martelet | M | 64 | 2 anni | |
| Frank Bobe | M | 66 | 10 anni | |
| Flemming Ørnskov | M | 66 | 4 anni | |
| Reinhard Ambros | M | 67 | 4 anni | |
| Carlos Garcia-Echeverria | M | 60 | 12 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Svizzera | 22 | 66.67% |
| Stati Uniti | 11 | 33.33% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Martin G. Friedman
- Contatti personali
